6533b862fe1ef96bd12c607c

RESEARCH PRODUCT

Telemedicina en el manejo de pacientes con enfermedad inflamatoria intestinal

Mariam AguasPilar NosRaquel FaubelJavier Del HoyoBernardo Valdivieso

subject

Gerontologymedicine.medical_specialtyTelemedicineHepatologybusiness.industryPatient EmpowermentGastroenterologyContext (language use)Diseasemedicine.diseaseHealth outcomesInflammatory bowel diseasedigestive system diseases03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisHealth caremedicineResource use030211 gastroenterology & hepatologybusinessIntensive care medicine

description

Inflammatory bowel disease (IBD) is a chronic and relapsing disorder with significant medical, social and financial impacts. IBD patients require continuous follow-up, and healthcare resource use in this context increases over time. In the last decade, telemedicine has influenced the treatment of chronic diseases like IBD via the application of information and communication technologies to provide healthcare services remotely. Telemedicine and its various applications (telemanagement, teleconsulting and tele-education) enable closer follow-up and provide education resources that promote patient empowerment, encouraging treatment optimisation over the entire course of the disease. We describe the impact of using telemedicine on IBD health outcomes and discuss the limitations of implementing these systems in the real-life management of IBD patients.

https://doi.org/10.1016/j.gastrohep.2017.07.001